5xj4: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Complex structure of durvalumab-scFv/PD-L1== | |||
<StructureSection load='5xj4' size='340' side='right' caption='[[5xj4]], [[Resolution|resolution]] 2.30Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[5xj4]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5XJ4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5XJ4 FirstGlance]. <br> | |||
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5xj3|5xj3]]</td></tr> | |||
[[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5xj4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5xj4 OCA], [http://pdbe.org/5xj4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5xj4 RCSB], [http://www.ebi.ac.uk/pdbsum/5xj4 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5xj4 ProSAT]</span></td></tr> | ||
[[ | </table> | ||
[[ | == Function == | ||
[[http://www.uniprot.org/uniprot/PD1L1_HUMAN PD1L1_HUMAN]] Involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation and cytokine production.<ref>PMID:10581077</ref> <ref>PMID:11015443</ref> | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Chai, Y]] | [[Category: Chai, Y]] | ||
[[Category: Gao, G F]] | |||
[[Category: Liu, K]] | [[Category: Liu, K]] | ||
[[Category: Qi, J]] | [[Category: Qi, J]] | ||
[[Category: Tan, S]] | |||
[[Category: Complex structure]] | |||
[[Category: Durvalumab]] | |||
[[Category: Immune system]] | |||
[[Category: Pd-l1]] | |||
Revision as of 05:28, 25 April 2018
Complex structure of durvalumab-scFv/PD-L1
| ||||||||||||
